[Advanced cancer of the ovary. Treatment and results]

other public-domain-us
View on PubMed
AI-generated summary by claude@2026-08, 2026-08-09

Sixty-five advanced ovarian cancer patients treated with aggressive surgery, chemotherapy, and second-look surgery showed a 43% response rate and 12% fourth-year survival without recurrence.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The management of advanced ovarian carcinoma (stages IIb, III, IV) is presented together with the results of treating a series of 65 patients at Gustave-Roussy Institute. The response rate was 43 p. cent with 16 complete remissions and 12 partial remissions out of 65 patients. Fourth year survival without recurrences was 12/65; 9/16 after complete remission at 2nd look, and 3/12 after partial remission. Treatment was by surgery--chemotherapy--2nd look surgery; radiotherapy and/or chemotherapy are decided on after 2nd look surgery. Each treatment should be agressive, prolonged, and multi-disciplinary.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Adenocarcinoma Cystadenocarcinoma Endometriosis Ovarian Neoplasms Adenocarcinoma Adenocarcinoma Aged Combined Modality Therapy Cystadenocarcinoma Cystadenocarcinoma Endometriosis Endometriosis Female Follow-Up Studies Humans Middle Aged Neoplasm Staging Ovarian Neoplasms Ovarian Neoplasms Ovarian Neoplasms

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-08-09T06:10:49.860119+00:00
pubmed
last seen: 2026-05-13T22:09:40.384591+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine